Date | Time | Source | Headline | Symbol | Company |
09/26/2024 | 4:32PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
09/26/2024 | 4:29PM | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | NASDAQ:AYTU | AYTU BioPharma Inc |
09/26/2024 | 4:05PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:AYTU | AYTU BioPharma Inc |
08/06/2024 | 8:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
06/18/2024 | 5:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
06/18/2024 | 4:30PM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:AYTU | AYTU BioPharma Inc |
06/18/2024 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
05/15/2024 | 4:12PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
05/10/2024 | 4:07PM | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:AYTU | AYTU BioPharma Inc |
05/10/2024 | 4:07PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:AYTU | AYTU BioPharma Inc |
05/10/2024 | 4:06PM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:AYTU | AYTU BioPharma Inc |
02/14/2024 | 4:12PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
02/13/2024 | 4:25PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AYTU | AYTU BioPharma Inc |
01/02/2024 | 4:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
11/17/2023 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
11/14/2023 | 4:05PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:AYTU | AYTU BioPharma Inc |
10/26/2023 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
10/12/2023 | 2:50PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:AYTU | AYTU BioPharma Inc |
10/06/2023 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
10/03/2023 | 4:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
09/29/2023 | 4:15PM | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:AYTU | AYTU BioPharma Inc |
09/27/2023 | 4:20PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AYTU | AYTU BioPharma Inc |
09/27/2023 | 7:28AM | IH Market News | Wednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and more | NASDAQ:AYTU | AYTU BioPharma Inc |
08/18/2023 | 6:27PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 8:57PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 7:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 7:39PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 7:38PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 7:34PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |
08/15/2023 | 7:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AYTU | AYTU BioPharma Inc |